myelodysplasia. 3 Sacchi S, Kantarjian H, O'Brien S, Cohen PR, Pierce S, Talpaz M.
The finding of aberrant cytogenetic evolution in CML under
Immune-mediated and unusual complications during interferon-IFN therapy appears to be a major problem and requires alfa therapy in chronic myelogenous leukemia. Blood 1995; 13:
further investigation on a larger series to elucidate the underly- 2401-2407. ing mechanisms and evaluate the influence of such chromo- 4 
Enhancement of mdr1 gene expression by transforming growth factor-␤1 in the new adriamycin-resistant human leukemia cell line ME-F 2 /ADM
Multidrug resistance (MDR) of tumor cells is a major problem increased in ME-F 2 /ADM100 and ME-F 2 /ADM200 cells in proportion to their respective level of drug resistance. in the treatment of cancer. The MDR phenotype is closely associated with overexpression of the mdr1 gene and its proWe examined whether cytokines could modulate the P-gp expression on ME-F 2 /ADM100 and ME-F 2 /ADM200 cells. The duct, P-glycoprotein (P-gp), which functions as an efflux pump preventing the intracellular accumulation of structurally unrecells (1 × 10 6 ) were incubated with the following cytokines at optimal concentration: IL-3 (100 U/ml), IL-4 (100 U/ml), IL-6 lated drugs. [1] [2] [3] [4] The levels of mdr1 mRNA and P-gp have been reported to be regulated by cytokines 5, 6 and various other (100 ng/ml), granulocyte colony-stimulating factor (100 U/ml), stem cell factor (100 ng/ml), erythropoietin (100 U/ml), interagents such as steroid hormone 7 and differentiating agents. 8 In the present study, we established adriamycin (ADM)-resistant feron-␥ (100 U/ml), leukemia inhibitory factor (1000 U/ml) and TGF-␤1 (10 U/ml) in 2 ml of medium for 24 h. TGF-␤1 sublines which expressed highly the mdr1 gene and P-gp, and demonstrated for the first time that this expression was increased markedly the P-gp expression on ME-F 2 /ADM100 and ME-F 2 /ADM200 cells, although none of the cytokines, increased by transforming growth factor (TGF)-␤1.
We selected two ADM-resistant sublines, ME-F 2 /ADM100 except for TGF-␤1, modulated the P-gp expression. Next we analyzed the effect of TGF-␤1 on the expression of mdr1 gene and ME-F 2 /ADM200 which could stably proliferate in 100 ng/ml and 200 ng/ml of ADM, respectively, from a human in ME-F 2 and ME-F 2 /ADM100 cells. As shown in Figure 1a , TGF-␤1 increased the expression of mdr1 gene in MEmyelomonocytic leukemia cell line, ME-F 2 , 9 by continuous exposure to a step-wise increase in the concentration of ADM. F 2 /ADM100 cells within 1 h, and the level was maintained for a further 24 h. By contrast, TGF-␤1 did not affect the ME-F 2 /ADM100 and ME-F 2 /ADM200 cells had a cross-resistance to daunorubicin and vincristine which was reversed by expression of mdr1 gene in ME-F 2 . This suggests that TGF-␤1 affects the mdr1 gene expression as an early effect in MEverapamil. The expression of the mdr1 gene and P-gp in parental ME-F 2 , ME-F 2 /ADM100 and ME-F 2 /ADM200 was ana-F 2 /ADM100 cells. Recent studies reported that protein kinase C (PKC)-mediated the activity of TGF-␤ signaling pathways lyzed by RT-PCR and flow cytometric analysis with the monoclonal antibody MRK16 (Kyowa Medex, Tokyo, Japan) as that lead to the activation of gene transcription. 12, 13 To elucidate the relationship between PKC and TGF-␤1 signaling described previously. 10 The primer sets of mdr1 and ␤ 2 -microglobulin (␤ 2 m) were chosen by Noonan et al. 11 Amplipathway, we further analyzed whether sphingosine, a specific PKC inhibitor, could inhibit the effect of TGF-␤1 on the fication was performed in a thermal cycler for 20 cycles (1 min at 94°C, 1 min at 55°C, and 1 min at 72°C). Neither expression of mdr1 gene in ME-F 2 and ME-F 2 /ADM100 cells. As shown in Figure 1b , the mdr1 gene expression in ME-PCR product of mdr1 nor P-gp expression were detected in ME-F 2 . However, the expression of mdr1 gene and P-gp was F 2 /ADM100 cells cotreated with sphingosine and TGF-␤1 was decreased to near the level of mdr1 expression in the nontreated ME-F 2 /ADM100 cells. This result shows that increase related signal transduction pathway in ME-F 2 /ADM100 cells.
we showed that TGF-␤1 itself could induce the mdr1 gene expression as an early effect without cell transformation. Although the role of TGF-␤1 in the drug-resistance phenotype is unclear, TGF-␤1 may contribute to malignant progression by promoting the acquisition of drug resistance.
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